Shengxian Li
- Molecular Biology
- Reproductive Medicine top 2%
- Biomedical Engineering top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Biomaterials top 5%
- Co-authors
- Tao TaoJixue WangXin‐Gui LiYong HuangMei‐Rong HuangChunxi WangRong HuangJianxun Ding
- Topics
- Ovarian function and disorders (19 papers)Nanoplatforms for cancer theranostics (9 papers)Reproductive Biology and Fertility (8 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Shengxian Li
88 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 133
- Molecular Biology 469
- Reproductive Medicine 372
- Biomedical Engineering 325
- Endocrinology, Diabetes and Metabolism 263
- Biomaterials 236
Countries citing papers authored by Shengxian Li
This map shows the geographic impact of Shengxian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengxian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengxian Li more than expected).
Fields of papers citing papers by Shengxian Li
This network shows the impact of papers produced by Shengxian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengxian Li. The network helps show where Shengxian Li may publish in the future.
Co-authorship network of co-authors of Shengxian Li
This figure shows the co-authorship network connecting the top 25 collaborators of Shengxian Li. A scholar is included among the top collaborators of Shengxian Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengxian Li. Shengxian Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 7 | |
| 6 | 9 | |
| 7 | 14 | |
| 8 | 26 | |
| 9 | 13 | |
| 10 | 6 | |
| 11 | 79 | |
| 12 | 14 | |
| 13 | 1 | |
| 14 | 18 | |
| 15 | 67 | |
| 16 | 34 | |
| 17 | 20 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 6 |
About Shengxian Li
Shengxian Li is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Endocrine and Autonomic Systems, having authored 95 papers that have together received 1.9k indexed citations. Recurring topics across this work include Ovarian function and disorders (19 papers), Nanoplatforms for cancer theranostics (9 papers) and Reproductive Biology and Fertility (8 papers). The work is most often cited by research in Reproductive Medicine (372 citations), Biomaterials (236 citations) and Endocrinology, Diabetes and Metabolism (263 citations). Shengxian Li has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Tao Tao, Jixue Wang, Xin‐Gui Li, Yong Huang, Mei‐Rong Huang, Chunxi Wang, Rong Huang, Jianxun Ding, Yun Sun and Jing Ma. Their work appears in journals such as PLoS ONE, Advanced Functional Materials and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.